论文信息 - Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial - 字舞流文

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial

M. Dimopoulos | G. Lazaridis | A. Psyrri | H. Kalofonos | G. Fountzilas | F. Zagouri | A. Koutras | I. Chryssogonidis | G. Koumakis | D. Tryfonopoulos | E. Razis | A. Kotsakis | G. Koliou | N. Kentepozidis | E. Psoma | E. Res